Upregulation of APE/ref-1 in recurrence stage I, non small cell lung cancer

Asian Cardiovascular and Thoracic Annals

Volumn 20, Issue 1, 2012, Pages 36-41

  Kang, Min Woong ^a   Kang, Shin Kwang ^a   Choi, Songyi ^a   Lee, Choong Sik ^a   Jeon, Byeong Hwa ^a   Lim, Seung Pyung ^a  

^a Chungnam National University   (South Korea)

Author keywords

Adenocarcinoma; Apurinic apyrimidinic endonuclease 1 ref 1; Non small cell lung cancer; Recurrence

Indexed keywords

APURINIC APYRIMIDINIC ENDONUCLEASE 1; ENDONUCLEASE; REDOX EFFECTOR FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; MALE; MEDIASTINUM LYMPH NODE; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL NUCLEUS; CYTOPLASM; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OXIDATIVE STRESS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84863231132     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492311432800     Document Type: Article

References (27)

1. Travis WD, Travis LB and Devesa SS. Lung cancer. Cancer 1995; 75(1 Suppl): 191-202.
2. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE and Fraumeni Jr JF. Recent cancer trends in the United States. J Natl Cancer Inst 1995; 87: 175-182.
3. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717. (Pubitemid 27260107)
4. Passlick B, Sienel W, Seen-Hibler R, Wöckel W, Thetter O, Mutschler W, et al. Overexpression of matrix metalloproteinase predicts unfavorable outcome in early stage non-small cell lung cancer. Clin Cancer Res 2000; 6: 3944-3948.
5. Kaynar H, Meral M, Turhan H, Keles M, Celik G and Akcay F. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett 2005; 227: 133-139. (Pubitemid 41169926)
6. Toyokuni S, Okamoto K and Yodoi, Hiai J. Persistent oxidative stress in cancer. FEBS Lett 1995; 358: 1-3.
7. Evans AR, Limp-Foster M and Kelley MR. Going APE over ref-1. Mutat Res 2000; 461: 83-108.
8. Grosch S, Fritz G and Kaina B. Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. Cancer Res 1998; 58: 4410-4416. (Pubitemid 28450044)
9. Silber JR, Bobola MS, Blank A, Schoeler KD, Haroldson PD, Huynh MB, et al. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress. Clin Cancer Res 2002; 8: 3008-3018. (Pubitemid 35025751)
10. Tomicic M, Eschbach E and Kaina B. Expression of yeast but not human apurinic/apyrimidinic endonuclease renders Chinese hamster cells more resistant to DNA damaging agents. Mutat Res 1997; 383: 155-165. (Pubitemid 27117567)
11. Fishel ML and Kelley MR. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target [Review]. Mol Aspects Med 2007; 28: 375-395. (Pubitemid 47331610)
12. Koukourakis MI, Giatromanolaki A, Kakolyris S, Sivridis E, Georgoulias V, Funtzilas G, et al. Nuclear expression of human apurinic/apyrimidinic endonuclease(HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemotherapy and poor outcome. Int J Rad Oncol Biol Phys 2001; 50: 27-36.
13. Zetter BR. Angiogenesis and tumor metastasis [Review]. Annu Rev Med 1999; 49: 407-424. (Pubitemid 28197463)
14. Puglisi F, Aprile G, Minisini AM, Barbone F, Cataldi P, Tell G, Kelley MR, et al. Prognostic significance of Ape1/Ref-1 subcellular localization in non-small cell lung carcinomas. Anticancer Res 2001; 21: 4041-4049. (Pubitemid 34229282)
15. Kakolyris S, Giatromanolaki A, Koukourakis M, Kaklamanis L, Kanavaros P, Hickson ID, et al. Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC). J Pathol 1999; 189: 351-357. (Pubitemid 29489219)
16. Yoo DG, Song YJ, Cho EJ, Lee SK, Park JB, Yu JH, et al. Alteration of APE/ref-1 expression in non-small cell lung cancer: The implication of impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung Cancer 2008; 60: 277-284. (Pubitemid 351622081)
17. Xanthoudakis S and Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA binding activity. EMBO J 1992; 11: 635-665.
18. Friedberg EC, Walker GC and Siede W. DNA repair and mutagenesis. Washington, DC: ASM Press, 1995, pp.169-175.
19. Fritz G, Grosch S, Tomicic M and Kaina B. Ape/ref-1 and the mammalian response to genotoxic stress [Review]. Toxicology 2003; 193: 67-78. (Pubitemid 37340144)
20. Jayaraman L, Murthy, Zhu C, Curran T, Xanthoudakis S and Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 1997; 11: 558-570. (Pubitemid 27133376)
21. Walker LJ, Craig RB, Harris AL and Hickson ID. A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res 1994; 22: 4884-4889.
22. Grosch S, Fritz G and Kaina B. Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. Cancer Res 1998; 58: 4410-4416. (Pubitemid 28450044)
23. Dewhirst MW, Cao Y and Moeller B. Cycling hypoxia and free radials regulate angiogenesis and radiotherapy response [Review]. Nat Rev Cancer 2008; 8: 426-437.
24. Semenza GL. Targeting HIF-1 for cancer therapy [Review]. Nat Rev Cancer 2003; 3: 721-732. (Pubitemid 37328811)
25. Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, et al. HIF-1,STAT3, CBP/p300 and Ref-1/ APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinoma. Oncogene 2005; 24: 3110-3120. (Pubitemid 40695080)
26. Vaupel P and Mayer A. Hypoxia in cancer; significance and impact on clinical outcome [Review]. Cancer Metastasis Rev 2007; 26: 224-239.
27. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008; 320: 661-664. (Pubitemid 351928347)